NSD2 and Miyoshi myopathy: This increase in H3K36me2 leads to reduced global levels of H3K27me3, as well as its focal redistribution, which is thought to support MM tumourigenesis, as MMSET overexpression results in increased sensitivity to EZH2 inhibition [152,153].